- World rank, all time
- #21,968 of 42,892
- Rank in United States
- #4,729 of 8,685
- Research works
- 199 ▼ 68% vs 2013–17
- Citations
- 1.6k 8.1 per fractional work
- Top-10% rate
- 11.5% record average 16.5%
- Open access
- 38% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Physics and Astronomy, 4.0×. Every wedge is a field page.
- Physics and Astronomy 4.0×
- Medicine 3.2×
- Business, Management and Accounting 1.3×
- Computer Science 1.2×
- Biochemistry, Genetics and Molecular Biology 0.7×
- Social Sciences 0.5×
- Economics, Econometrics and Finance 0.5×
- Dentistry 0.5×
- Engineering 0.2×
- Health Professions 0.2×
- Neuroscience 0.2×
- Materials Science 0.1×
Who are the top researchers at ProCure (United States)?
Ranked on the composite score, Dennis Mah, Eugen B. Hug and Suresh Rana lead among researchers whose main affiliation is ProCure (United States).
- 1 Dennis Mah United States · #788,168 worldwide 19 citations · 22 works
- 2 Eugen B. Hug United States · #917,628 worldwide 49 citations · 44 works
- 3 Suresh Rana United States · #1,020,798 worldwide 27 citations · 19 works
- 4 Brian Chon United States · #1,128,380 worldwide 21 citations · 16 works
- 5 Gary Larson United States · #1,181,671 worldwide 15 citations · 16 works
Which keywords describe research at ProCure (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Dosimetry, Monte Carlo Simulation, Image-Guided Radiotherapy, Radiotherapy Physics, Clinical Applications, Particle Therapy, Proton Therapy and Radiotherapy.
- Spectral Imaging
- Carboranes
- Drug Design
- Imaging
- Reconstruction
- Screening
- Clinical Guidelines
- Nasopharyngeal Carcinoma
- Biopsy
- Human Rights
- Survival
- Squamous Cell Carcinoma
- Inorganic Scintillators
- Prostate Cancer
- Immunotherapy
- Medical Imaging
- Radiotherapy
- Particle Therapy
- Radiotherapy Physics
- Monte Carlo Simulation
- Dosimetry
- Image-Guided Radiotherapy
- Clinical Applications
- Proton Therapy
- Chemotherapy
- Artificial Intelligence
- Clinical Practice Guidelines
- Legal Regulation
- Scintillation Detectors
- Prognosis
- Cancer Treatment
- Radiation Therapy
- Human Papillomavirus
- Oropharyngeal Cancer
- Gleason Grading
- Prognostic Factors
- Molecular Classification
- PET/CT
- Boron Neutron Capture Therapy
- Blockchain Technology
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Dosimetry35▲ 190×2 topics
- Monte Carlo Simulation35▲ 57×4 topics
- Image-Guided Radiotherapy34▲ 330×1 topic
- Radiotherapy Physics34▲ 330×1 topic
- Clinical Applications31▲ 209×2 topics
- Particle Therapy31▲ 480×1 topic
- Proton Therapy31▲ 480×1 topic
- Radiotherapy18▲ 24×10 topics
- Chemotherapy10▲ 7.2×12 topics
- Medical Imaging8▲ 14×3 topics
- Artificial Intelligence7▲ 4.3×10 topics
- Immunotherapy6▲ 4.9×12 topics
- Clinical Practice Guidelines6▲ 5.5×9 topics
- Prostate Cancer6▲ 21×3 topics
- Legal Regulation6▲ 29×6 topics
- Inorganic Scintillators6▲ 69×1 topic
- Scintillation Detectors6▲ 69×1 topic
- Squamous Cell Carcinoma6▲ 33×3 topics
- Prognosis6▲ 9.1×3 topics
- Survival6▲ 22×3 topics
- Cancer Treatment5▲ 10×6 topics
- Human Rights5▲ 3.1×11 topics
- Radiation Therapy5▲ 18×5 topics
- Biopsy5▲ 35×2 topics
- Human Papillomavirus5▲ 20×2 topics
- Nasopharyngeal Carcinoma5▲ 49×1 topic
- Oropharyngeal Cancer5▲ 49×1 topic
- Clinical Guidelines5▲ 7.6×2 topics
- Gleason Grading5▲ 54×1 topic
- Screening5▲ 25×1 topic
- Prognostic Factors4▲ 5.0×10 topics
- Reconstruction4▲ 10×3 topics
- Molecular Classification4▲ 13×4 topics
- Imaging4▲ 5.1×1 topic
- PET/CT4▲ 24×1 topic
- Drug Design3▲ 14×2 topics
- Boron Neutron Capture Therapy3▲ 135×1 topic
- Carboranes3▲ 135×1 topic
- Blockchain Technology3▲ 60×2 topics
- Spectral Imaging3▲ 24×2 topics
Which research topics does ProCure (United States) publish most on?
By volume in 2022–2025: Radiation Therapy and Dosimetry, Information and Cyber Security, Advanced Radiotherapy Techniques and Head and Neck Cancer Studies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Radiation Therapy and Dosimetry Pulmonary and Respiratory Medicine 1 works
- 2 Information and Cyber Security Information Systems 1 works
- 3 Advanced Radiotherapy Techniques Radiation 1 works
- 4 Head and Neck Cancer Studies Otorhinolaryngology 1 works
- 5 Oral health in cancer treatment Pulmonary and Respiratory Medicine 0 works
- 6 Dispute Resolution and Class Actions Strategy and Management 0 works
- 7 Legal principles and applications Law 0 works
- 8 Muscle activation and electromyography studies Biomedical Engineering 0 works
- 9 Glioma Diagnosis and Treatment Genetics 0 works
- 10 Conflict of Laws and Jurisdiction Political Science and International Relations 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has ProCure (United States)'s research output changed?
Output in 2018–2022 was 68% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Somerset
- Vifor Pharma (United States)
- Montgomery High School
- University Orthopaedic Associates
- Catalent (United States)
- Terumo (United States)
- Orthopaedic Center of New Jersey
- NEI Corporation (United States)
- Light Age (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.